about
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesAHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 UpdatePreprints for the life sciencesState Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warningPatterns of weight change preceding hospitalization for heart failureBRIEF REPORT: nutrition and weight loss information in a popular diet book: is it fact, fiction, or something in between?Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysisAn application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validationVolume-based referral for cardiovascular procedures in the United States: a cross-sectional regression analysisPolypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA GuidelineRole of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetesData sharing through an NIH central database repository: a cross-sectional survey of BioLINCC usersData Acquisition, Curation, and Use for a Continuously Learning Health SystemChina Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study Design.Symptom recognition and healthcare experiences of young women with acute myocardial infarction.Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarctionIs there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 studyAspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort studyThe case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs: is it time to believe the hype?Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarctionAspirin and the treatment of heart failure in the elderlyQuality of medical care and excess mortality in older patients with mental disordersQuality of care among elderly patients hospitalized with unstable anginaSex and racial differences in the management of acute myocardial infarction, 1994 through 2002Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomesPrior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarctionNonsteroidal antiinflammatory drugs after acute myocardial infarctionRisk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular ProjectEvaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality dataThe Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomesQuality of care of Medicare beneficiaries with acute myocardial infarction: who is included in quality improvement measurement?JCAHO accreditation and quality of care for acute myocardial infarctionEffects of age on the quality of care provided to older patients with acute myocardial infarctionEffect of ibuprofen on cardioprotective effect of aspirinNational and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the medicare health care quality improvement programPhysician board certification and the care and outcomes of elderly patients with acute myocardial infarctionAspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarctionRegional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantageHospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality
P50
Q22241919-2733B7E4-A468-4F42-987C-33A975F92295Q22252415-4D5FF366-3043-4F8C-807F-1CB5C60FE58CQ24204885-3F6A7ECB-2F73-45A4-82A1-A1C00D9D3A66Q24604853-8F8F7DCC-A4F1-4409-969E-CFAB257E2AB3Q24628173-2DCFD57C-F26E-40D8-8BC1-C128A2AC1105Q24670388-DA25375C-4D24-4E83-B5B5-4934F8A7774AQ24718169-8041B244-BF0E-4E0C-AFA1-828961400141Q24804221-BAC4375A-A091-4C93-BE16-3F9B33CDCCB6Q24810902-4A6C74E2-C654-4A30-BB43-674D8A65C454Q26767283-F8903C46-53D8-4B1B-90AA-A7E12FE30CD3Q26779649-8189A7FC-E29A-4A6E-B359-2798263B0DFEQ27004274-32393E9D-938E-4807-B1DF-D13A221E57BBQ27077662-7BB900E5-C39A-4E5F-AD54-3581C72DA1F6Q27206839-208D680A-B34C-4B25-8406-B34DAACCEB3DQ27302208-8095520B-29D6-44D7-9636-2E956A1E027DQ27339799-0BD7DCBC-6461-444E-9784-9B48559E186EQ28165294-92C79977-412A-4B81-9212-3C21A1F62966Q28165940-9842E2E4-3135-465C-8E16-57A3854CBD88Q28166368-1913BDC8-635D-4B19-8945-77D0836C16AEQ28167858-F9424DDD-3BFA-4EE1-A2D8-F787F4F70BD7Q28177216-632C7AFF-942D-42AB-A9AC-96E143607EF7Q28177229-008BC49A-60AE-4D09-970F-49248B0B51E9Q28184670-F0EA561D-E6D7-4216-91D1-5B5C717A6938Q28187164-81FBC1E8-256D-44FE-917B-722DCEA7E1ECQ28188255-72D9F1EC-7414-4A1A-866C-3B1BF36DA587Q28191939-229B6DE7-05A2-4778-9A9B-1EDFCC833C41Q28191948-ECAE9228-CBF2-4BE6-87D0-A4D3C59931B9Q28192441-49779E8C-F4C9-410A-AF57-EFFBB261B845Q28192478-6F3DC864-21DB-4A7A-A712-B86EAE3C638FQ28192498-9748C2D8-26E7-4EA5-9F73-FC54FDBB795EQ28195416-8AE7ABFB-A2FE-48A3-9608-F0940C137ED6Q28195495-9BC5B45A-BD57-4962-AD84-2F5F7F6BB6E7Q28195588-274E65C3-F140-4EE9-B282-38955437603AQ28195627-09A9A5C0-865A-4C14-972D-48FE79100F4AQ28195884-DA7569B3-2810-45E9-9CAE-E97E06101ABCQ28196523-D73C8DDA-ED54-4938-8641-F7B164CCE54AQ28196759-7D234E42-E00A-4803-81B1-375E9A703141Q28196824-B6243A9B-1AAE-4CAB-B386-234048172ABDQ28196905-5CC72FE1-ECEA-4112-8B74-41CDC5974E57Q28199043-0A1EEA86-0A17-49FD-91DA-B90BB59188F1
P50
description
cardiologist and healthcare researcher at Yale University
@en
hulumtues
@sq
wetenschapper
@nl
հետազոտող
@hy
name
Harlan M. Krumholz
@ast
Harlan M. Krumholz
@da
Harlan M. Krumholz
@de
Harlan M. Krumholz
@en
Harlan M. Krumholz
@es
Harlan M. Krumholz
@fo
Harlan M. Krumholz
@fr
Harlan M. Krumholz
@is
Harlan M. Krumholz
@kl
Harlan M. Krumholz
@nb
type
label
Harlan M. Krumholz
@ast
Harlan M. Krumholz
@da
Harlan M. Krumholz
@de
Harlan M. Krumholz
@en
Harlan M. Krumholz
@es
Harlan M. Krumholz
@fo
Harlan M. Krumholz
@fr
Harlan M. Krumholz
@is
Harlan M. Krumholz
@kl
Harlan M. Krumholz
@nb
altLabel
Harlan Krumholz
@en
Harlan M Krumholz
@en
prefLabel
Harlan M. Krumholz
@ast
Harlan M. Krumholz
@da
Harlan M. Krumholz
@de
Harlan M. Krumholz
@en
Harlan M. Krumholz
@es
Harlan M. Krumholz
@fo
Harlan M. Krumholz
@fr
Harlan M. Krumholz
@is
Harlan M. Krumholz
@kl
Harlan M. Krumholz
@nb
P106
P2002
P21
P31
P496
0000-0003-2046-127X
P5008
P569
2000-01-01T00:00:00Z